All Cosmos Bio-Tech Holding Corporation (4148.TW) TAI

Currency In TWD

AD

Valuation

Market Cap3.46B
Enterprise Value2.62B
P/E Ratio13.81
PEG Ratio0.61
Price/Sales Ratio0.68
Price/Book Ratio2
Enterprise/Revenue0.32
Enterprise/EBITDA2.71

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.05
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.06

Income Statement

Revenue2.95B
Revenue/Share15.93
Gross Profit829.47M
EBITDA362.56M
Net Income153M
Diluted EPS2.28

Balance Sheet

Total Cash1.54B
Total Cash/Share8.38
Total Debt285.38M
Total Debt/Equity0.1
Current Ratio4.73
Book Value Per Share18.69

Price History

52-Week Change-23.79
52-Week High44.9
52-Week Low29.4
Moving Average 50 Days34.65
Moving Average 200 Days38.15

Statistics

Average Volume80,181
Shares Outstanding67.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield1.68
Payout Ratio0.22
Last Split Factor21:20
Last Split DateAugust 14, 2025
AD